This study investigates the perception of a multinational group of nephrologists on artificial intelligence (AI) application in clinical practice. A validated on-line survey was performed in March 2024, in 4 continents. The results revealed a prevalent familiarity with AI and machine learning (ML) terms, but traditional tools remained favored for clinical decision support. AI’s future relevance was acknowledged by more than two thirds of the sample but concerns related to the use of this tool in clinical practice were shared, particularly by nephrologists without any previous contact with AI. This reinforces the need for education in this group of health professionals, to allow full adoption of AI in the management of chronic kidney disease (CKD) in the near future.
No takes yet. Share an insight, caveat, or question.
Silva et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: